This letter outlines the agreement between bgC3 LLC and Dr. Boris Nikolic regarding the purchase by bgC3 of Dr. Nikolic's interest in a $30 Million to $50 Million Investment Entity. It details the termination of Dr. Nikolic's employment and financial relationships with bgC3 and related entities, the sale and purchase terms of the investment interest, advance payments, and the handling of investments in Foundation Medicine, Inc. and ResearchGate GmbH. The agreement includes provisions for Investment Entity Payment Demands, fair market value calculations, and payment terms.
documents/EFTA01083292.pdf
{}